Psychedelic experiences in clinical settings | Letters
If clinicians cannot put the experience into words, then how can patients give informed consent that meets the robust medico-legal standard, asks Dr Caroline Hayes
Although it is refreshing to read a more balanced article on psychedelics (Experts warn of mental health risks after rise in magic mushroom use, 25 December), we must be cautious about accepting the paternalistic notion that the clinical setting is always the most appropriate.
“Set and setting” – one’s mindset and the physical and social environment – are hugely influential on the psychedelic experience, and for some marginalised communities and patient groups, the medical establishment may be associated with difficult or traumatic experiences, and therefore not the ideal setting for taking psychedelics. This is perhaps reflected in the lack of diversity of psychedelic clinical trial participants. Although this is a problem across clinical research as a whole, it is more of a concern for psychedelic trials as the psychedelic experience is very culturally specific.
Continue reading...
By Guardian Staff
Psychedelic experiences in clinical settings | Letters to Continue reading...
NHS Forums - For NHS Staff | Patient Forums
If clinicians cannot put the experience into words, then how can patients give informed consent that meets the robust medico-legal standard, asks Dr Caroline Hayes
Although it is refreshing to read a more balanced article on psychedelics (Experts warn of mental health risks after rise in magic mushroom use, 25 December), we must be cautious about accepting the paternalistic notion that the clinical setting is always the most appropriate.
“Set and setting” – one’s mindset and the physical and social environment – are hugely influential on the psychedelic experience, and for some marginalised communities and patient groups, the medical establishment may be associated with difficult or traumatic experiences, and therefore not the ideal setting for taking psychedelics. This is perhaps reflected in the lack of diversity of psychedelic clinical trial participants. Although this is a problem across clinical research as a whole, it is more of a concern for psychedelic trials as the psychedelic experience is very culturally specific.
Continue reading...
By Guardian Staff
Psychedelic experiences in clinical settings | Letters to Continue reading...
NHS Forums - For NHS Staff | Patient Forums
